Aytu Historical Financial Ratios
AYTU Stock | USD 1.62 0.02 1.25% |
Aytu BioScience is presently reporting on over 103 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Dividend Yield of 0.0, PTB Ratio of 3.34 or Days Sales Outstanding of 106 will help investors to properly organize and evaluate Aytu BioScience financial condition quickly.
Aytu |
About Aytu Financial Ratios Analysis
Aytu BioScienceFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Aytu BioScience investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Aytu financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Aytu BioScience history.
Aytu BioScience Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Aytu BioScience stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Aytu BioScience sales, a figure that is much harder to manipulate than other Aytu BioScience multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Book Value Per Share
The ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements.Most ratios from Aytu BioScience's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Aytu BioScience current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aytu BioScience. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more information on how to buy Aytu Stock please use our How to Invest in Aytu BioScience guide.At this time, Aytu BioScience's Research And Ddevelopement To Revenue is comparatively stable compared to the past year. Cash Per Share is likely to gain to about 293.3 K in 2024, whereas Operating Cash Flow Per Share is likely to drop (611.3 K) in 2024.
2021 | 2022 | 2023 | 2024 (projected) | Days Sales Outstanding | 81.98 | 98.34 | 106.42 | 106.07 | PTB Ratio | 0.44 | 0.14 | 0.57 | 3.34 |
Aytu BioScience fundamentals Correlations
Click cells to compare fundamentals
Aytu BioScience Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Aytu BioScience fundamentals Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Price To Sales Ratio | 2.36 | 1.28 | 0.21 | 0.0498 | 0.19 | 303.96 | |
Ptb Ratio | 0.69 | 0.61 | 0.44 | 0.14 | 0.57 | 3.34 | |
Days Sales Outstanding | 74.41 | 156.7 | 81.98 | 98.34 | 106.42 | 106.07 | |
Book Value Per Share | 413.11 | 163.77 | 31.36 | 11.78 | 5.0 | 596.6K | |
Free Cash Flow Yield | (0.43) | (0.34) | (1.42) | (0.96) | (0.0879) | (0.31) | |
Operating Cash Flow Per Share | (123.36) | (30.91) | (19.61) | (1.54) | (0.25) | (611.3K) | |
Stock Based Compensation To Revenue | 0.039 | 0.0545 | 0.0543 | 0.0563 | 0.036 | 8.48 | |
Capex To Depreciation | 0.0288 | 0.0219 | 0.25 | 0.0954 | 0.11 | 0.1 | |
Pb Ratio | 0.69 | 0.61 | 0.44 | 0.14 | 0.57 | 3.34 | |
Ev To Sales | 0.7 | 0.96 | 0.2 | (0.0119) | 0.13 | 337.23 | |
Free Cash Flow Per Share | (123.36) | (33.7) | (19.61) | (1.54) | (0.25) | (612.4K) | |
Roic | (0.0592) | (0.23) | 0.58 | (0.31) | (0.14) | (1.03) | |
Net Income Per Share | (1.2K) | (59.22) | (69.39) | (5.1) | (2.86) | (619.9K) | |
Days Of Inventory On Hand | 483.22 | 163.69 | 89.21 | 107.4 | 174.56 | 241.62 | |
Payables Turnover | 0.65 | 1.89 | 4.04 | 3.02 | 2.53 | (7.05) | |
Research And Ddevelopement To Revenue | 0.0623 | 0.0857 | 0.15 | 0.0381 | 0.0345 | 68.88 | |
Capex To Revenue | 0.0204 | 0.008176 | 0.0357 | 0.16 | 0.18 | 0.17 | |
Cash Per Share | 209.05 | 59.11 | 13.17 | 6.88 | 3.61 | 293.3K | |
Pocfratio | (2.3) | (3.24) | (0.7) | (1.04) | (11.37) | (3.26) | |
Capex To Operating Cash Flow | (0.004687) | (0.004327) | (0.0902) | (0.00169) | (0.001521) | (0.001597) | |
Pfcf Ratio | (2.3) | (2.97) | (0.7) | (1.04) | (11.37) | (3.25) | |
Days Payables Outstanding | 562.5 | 192.91 | 90.35 | 120.67 | 144.25 | (51.76) | |
Income Quality | 2.08 | 0.45 | 0.26 | 0.3 | 0.0876 | 0.99 | |
Roe | (0.14) | (0.42) | (2.36) | (0.43) | (0.57) | (1.04) | |
Ev To Operating Cash Flow | (0.68) | (2.42) | (0.66) | 0.25 | (7.86) | (3.61) | |
Pe Ratio | (4.8) | (1.44) | (0.19) | (0.31) | (1.0) | (3.21) | |
Return On Tangible Assets | (0.18) | (0.51) | (1.62) | (0.22) | (0.24) | (1.46) | |
Ev To Free Cash Flow | (0.68) | (2.22) | (0.66) | 0.25 | (7.86) | (3.61) | |
Earnings Yield | (0.21) | (0.69) | (5.36) | (3.19) | (1.0) | (0.31) | |
Net Debt To E B I T D A | 3.77 | 0.73 | 0.0419 | 1.89 | 4.82 | (37.19) | |
Current Ratio | 2.65 | 0.96 | 0.93 | 1.06 | 0.99 | 0.54 | |
Tangible Book Value Per Share | 78.57 | (16.31) | (16.69) | (5.87) | (4.47) | (314.5K) | |
Receivables Turnover | 4.91 | 2.33 | 4.45 | 3.71 | 3.43 | 5.82 | |
Graham Number | 741.91 | 505.67 | 228.49 | 36.79 | 17.95 | 2.9M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Aytu Stock Analysis
When running Aytu BioScience's price analysis, check to measure Aytu BioScience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aytu BioScience is operating at the current time. Most of Aytu BioScience's value examination focuses on studying past and present price action to predict the probability of Aytu BioScience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aytu BioScience's price. Additionally, you may evaluate how the addition of Aytu BioScience to your portfolios can decrease your overall portfolio volatility.